Kansas City Life Insurance (OTCMKTS:KCLI) Posts Quarterly Earnings Results

Kansas City Life Insurance (OTCMKTS:KCLIGet Free Report) released its quarterly earnings results on Tuesday. The financial services provider reported ($1.30) earnings per share (EPS) for the quarter, Zacks reports. Kansas City Life Insurance had a return on equity of 9.34% and a net margin of 10.10%.

Kansas City Life Insurance Stock Performance

KCLI stock traded up $0.13 during trading on Tuesday, hitting $34.63. The stock had a trading volume of 100 shares, compared to its average volume of 1,004. The company’s 50 day moving average price is $35.70 and its two-hundred day moving average price is $36.00. Kansas City Life Insurance has a 1-year low of $34.11 and a 1-year high of $39.01. The stock has a market cap of $335.27 million, a price-to-earnings ratio of 5.91 and a beta of 0.58.

Kansas City Life Insurance Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, February 12th. Investors of record on Thursday, February 6th were paid a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 1.62%. The ex-dividend date was Thursday, February 6th. Kansas City Life Insurance’s payout ratio is 9.56%.

Kansas City Life Insurance Company Profile

(Get Free Report)

Kansas City Life Insurance Company provides insurance products and services in states and the District of Columbia. It operates through three segments: Individual Insurance, Group Insurance, and Old American. The Individual Insurance segment consists of individual insurance products for Kansas City life, Grange life, and the assumed reinsurance transactions.

Recommended Stories

Earnings History for Kansas City Life Insurance (OTCMKTS:KCLI)

Receive News & Ratings for Kansas City Life Insurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kansas City Life Insurance and related companies with MarketBeat.com's FREE daily email newsletter.